Literature DB >> 21864023

Antioxidants and self-reported history of kidney stones: the National Health and Nutrition Examination Survey.

Peter A Holoch1, Chad R Tracy.   

Abstract

BACKGROUND AND
PURPOSE: Animal studies have demonstrated the likely role of oxidative tissue damage in the pathophysiology of stone disease; however, the effect of antioxidants on stone formation in the human population is unknown. We evaluated the association between serum antioxidant levels and the self-reported prevalence of kidney stones in a large cross-sectional population in a retrospective cohort study.
MATERIALS AND METHODS: Serum levels of antioxidants among adult participants in the National Health and Nutrition Examination Survey (NHANES III) 1988-1994 were compared between those with and without a self-reported history of kidney stones, adjusting for covariates of age, sex, body mass index (BMI), race/ethnicity, diabetes, and hypertension.
RESULTS: The prevalence of kidney stones was 5.25% (95% confidence interval: 4.60%, 5.90%). The prevalence of kidney stones was higher in males, white/non-Hispanics, diabetics, and those with hypertension. The prevalence of kidney stones increased with BMI. After adjusting for covariates, mean levels of alpha-carotene, beta-carotene, and beta-cryptoxanthin were significantly lower in those with kidney stones (-9.36%, -10.79%, and -8.48%, respectively). When analyzed by quartile, higher serum levels of beta-carotene and beta-cryptoxanthin,, trended toward a decreasing prevalence of stones (P=0.007 and P=0.03, respectively), indicating that the highest levels of these antioxidants may protect against the formation of kidney stones.
CONCLUSIONS: Lower levels of alpha-carotene, beta-carotene, and beta-cryptoxanthin are associated with a history of kidney stones and may indicate a role for these antioxidants in preventing stone formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864023     DOI: 10.1089/end.2011.0130

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  20 in total

1.  Risk of Nephrolithiasis in Patients With Sleep Apnea: A Population-Based Cohort Study.

Authors:  Sheng-Han Tsai; Marshall L Stoller; Benjamin A Sherer; Zi-Hao Chao; Tao-Hsin Tung
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

2.  Circadian Periodicity of Circulating Plasma Lipid Peroxides, Uric Acid and Ascorbic Acid in Renal Stone Formers.

Authors:  Rajeev Singh Kushwaha; R C Gupta; J P Sharma; Sumita Sharma; Raj Kumar Singh; Germaine Cornelissen
Journal:  Indian J Clin Biochem       Date:  2016-07-15

3.  Protective impact of resveratrol in experimental rat model of hyperoxaluria.

Authors:  Taylan Oksay; Sedat Yunusoğlu; Mustafa Calapoğlu; I Aydın Candan; İbrahim Onaran; Osman Ergün; Alper Özorak
Journal:  Int Urol Nephrol       Date:  2017-02-09       Impact factor: 2.370

4.  Oxidative stress and nephrolithiasis: a comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls.

Authors:  Chad R Tracy; Jonathan R Henning; Mark R Newton; Michael Aviram; M Bridget Zimmerman
Journal:  Urolithiasis       Date:  2014-08-02       Impact factor: 3.436

Review 5.  Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.

Authors:  Saeed R Khan
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

6.  Adolescents with urinary stones have elevated urine levels of inflammatory mediators.

Authors:  Kirsten Kusumi; John Ketz; Vijay Saxena; John David Spencer; Fayez Safadi; Andrew Schwaderer
Journal:  Urolithiasis       Date:  2019-04-16       Impact factor: 3.436

7.  Is oxidative stress related to childhood urolithiasis?

Authors:  Nilufer Göknar; Faruk Oktem; Engin Arı; Aysegul Doğan Demir; Emel Torun
Journal:  Pediatr Nephrol       Date:  2014-02-14       Impact factor: 3.714

8.  Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.

Authors:  Mohammad Reza Naghii; Eslam Eskandari; Mahmood Mofid; Mehdi Jafari; Mohammad Hossein Asadi
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

Review 9.  Nephrolithiasis and hypertension: possible links and clinical implications.

Authors:  Adamasco Cupisti; Claudia D'Alessandro; Sara Samoni; Mario Meola; Maria Francesca Egidi
Journal:  J Nephrol       Date:  2014-02-28       Impact factor: 3.902

Review 10.  Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Authors:  Saeed R Khan; Benjamin K Canales; Paul R Dominguez-Gutierrez
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.